Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Create Stock SIPAutomate your investments in this
Performance
Open
167.18Prev. Close
167.18Volume
76,074Total traded value
1.26 CrUpper Circuit
199.30Lower Circuit
132.87Fundamentals
| Market Cap | ₹803Cr |
| ROE | 7.44% |
| P/E Ratio(TTM) | 23.02 |
| EPS(TTM) | 7.23 |
| P/B Ratio | 1.55 |
| Dividend Yield | 1.80% |
| Industry P/E | 34.99 |
| Book Value | 107.35 |
| Debt to Equity | 0.29 |
| Face Value | 10 |
Understand Fundamentals
Financials
About Kopran
Kopran Limited is an integrated pharmaceutical company dedicated to producing and supplying international quality formulations and Active Pharmaceutical Ingredients (APIs) to customers worldwide. As a socially conscious organization, the company's goal is to provide medicines to people at affordable prices, upholding care and integrity in all its actions. The company's products have a significant global footprint, with an export reach extending to over 50 countries across various continents.;
| Parent Organisation | Kopran Limited |
| Managing Director | NA |
| NSE Symbol | KOPRAN |
Shareholding Pattern
Sep '24
Dec '24
Mar '25
Jun '25
Sep '25
Similar Stocks
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Cohance Lifesciences | NA (0.00%) | 103.62 | ||
| JB Chemicals & Pharmaceuticals | NA (0.00%) | 38.70 | ||
| Emcure Pharmaceuticals | NA (0.00%) | 33.14 | ||
| Wockhardt | NA (0.00%) | -146.62 |